Retatrutide
Triple GIP / GLP-1 / glucagon receptor agonist reference peptide for metabolic research.
Unit Price
$140.00
- Latest Lot
- —
- Availability
- Restocking
Technical Specifications
Storage & Handling
Store lyophilized at -20°C, protected from light.
Reconstitute in a sterile setting. Aliquot to limit freeze-thaw cycles.
Overview
Retatrutide is a triple-agonist reference peptide studied in metabolic-pathway research involving GIP, GLP-1, and glucagon receptor signaling. Supplied lyophilized.
Research Context
Used in preclinical research characterizing triple-incretin receptor activity. For laboratory research use only.
Certificates of Analysis
Certificates for this compound are available on request.
All materials are sold strictly for laboratory and research use only. Not for human or veterinary consumption.
Related Compounds
Semaglutide
5 mg lyophilized vialGLP-1 receptor agonist analog used as a reference standard in incretin-pathway research.
- Formula
- C187H291N45O59
- CAS
- 910463-68-2
- Mol. Weight
- 4113.58 g/mol
- Purity
- ≥ 99%
Tirzepatide
5 mg lyophilized vialDual GIP / GLP-1 receptor agonist reference compound for incretin co-agonism research.
- Formula
- C225H348N48O68
- CAS
- 2023788-19-2
- Mol. Weight
- 4813.45 g/mol
- Purity
- ≥ 99%
BPC-157
10 mg lyophilized vialSynthetic pentadecapeptide widely used as a reference compound in tissue-repair research models.
- Formula
- C62H98N16O22
- CAS
- 137525-51-0
- Mol. Weight
- 1419.53 g/mol
- Purity
- ≥ 99%